Literature DB >> 1919886

Serum cholesterol levels during and after Kawasaki disease.

E Salo1, E Pesonen, J Viikari.   

Abstract

Serum total cholesterol and high-density lipoprotein (HDL) cholesterol concentrations were studied in paired sera from 23 patients (16 boys) with Kawasaki disease (KD) during acute illness and in 35 patients (21 boys) 5.4 to 7.7 years after KD. Total cholesterol and HDL cholesterol concentrations were significantly lower (paired t test, p = 0.0001) in samples taken within 30 days of the onset of illness (3.32 +/- 0.85 mmol/L (128 +/- 33 mg/dl) and 0.54 +/- 0.25 mmol/L (20.8 +/- 9.7 mg/dl) than in the second samples taken 2 to 16 months after onset of disease (4.16 +/- 0.93 mmol/L (161 +/- 35 mg/dl) and 1.24 +/- 0.35 mmol/L (47.2 +/- 13.9 mg/dl). The lowest total cholesterol levels were observed in samples taken 6 to 9 days after the onset of KD (p = 0.019). No correlations were seen between the highest erythrocyte sedimentation rate, C-reactive protein, or thrombocyte counts and the acute or convalescent cholesterol levels. In patients studied 5.4 to 7.7 years after recovery from KD, the mean total cholesterol concentrations were still lower than in healthy Finnish children. In girls the HDL cholesterol concentrations were similar, whereas 3 of the 18 boys studied had HDL cholesterol values more than 2 SDs below the mean for healthy boys. There was no correlation between the serum cholesterol concentrations and coronary artery abnormalities. These data lead us to infer that KD does not cause such permanent changes in cholesterol metabolism as to be considered a risk factor for atherosclerosis beyond that caused by the disease itself.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1919886     DOI: 10.1016/s0022-3476(05)82404-7

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  9 in total

1.  The role of atorvastatin in regulating the immune response leading to vascular damage in a model of Kawasaki disease.

Authors:  S Blankier; B W McCrindle; S Ito; R S M Yeung
Journal:  Clin Exp Immunol       Date:  2011-03-01       Impact factor: 4.330

2.  Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease.

Authors:  Hong-Ren Yu; Ho-Chang Kuo; Eng-Yen Huang; Chi-Di Liang; Kao-Pin Hwang; I-Chun Lin; Jiunn-Ming Sheen; Tzu-Jou Wang; Chih-Lu Wang; Kuender D Yang
Journal:  Pediatr Cardiol       Date:  2010-08-15       Impact factor: 1.655

Review 3.  Kawasaki syndrome.

Authors:  A H Rowley; S T Shulman
Journal:  Clin Microbiol Rev       Date:  1998-07       Impact factor: 26.132

4.  Plasma clusterin concentrations may predict resistance to intravenous immunoglobulin in patients with Kawasaki disease.

Authors:  Mei-Chen Ou-Yang; Ho-Chang Kuo; I-Chun Lin; Jiunn-Ming Sheen; Fu-Chen Huang; Chih-Cheng Chen; Ying-Hsien Huang; Ying-Jui Lin; Hong-Ren Yu
Journal:  ScientificWorldJournal       Date:  2013-07-15

Review 5.  Vascular health late after Kawasaki disease: implications for accelerated atherosclerosis.

Authors:  Yiu-Fai Cheung
Journal:  Korean J Pediatr       Date:  2014-11-30

Review 6.  Kawasaki disease for dermatologists.

Authors:  Aman Gupta; Surjit Singh
Journal:  Indian Dermatol Online J       Date:  2016 Nov-Dec

Review 7.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

Review 8.  Current perspectives on Kawasaki disease.

Authors:  Monesha Gupta-Malhotra; P Syamasundar Rao
Journal:  Indian J Pediatr       Date:  2005-07       Impact factor: 1.967

9.  Arterial stiffness late after Kawasaki disease in children: Assessment by performing brachial-ankle pulse wave velocity.

Authors:  Kuang-Jen Chien; Hurng-Wern Huang; Ken-Pen Weng; Shih-Hui Huang; Sung-Chou Li; Chu-Chuan Lin; Kai-Sheng Hsieh
Journal:  J Chin Med Assoc       Date:  2020-10       Impact factor: 3.396

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.